Clinical Trials on 代谢性疾病 in New Zealand
总计44099个结果
-
KAI PharmaceuticalsTrident Clinical Research Pty Ltd完全的
-
Malaghan Institute of Medical ResearchWellington Zhaotai Therapies Limited主动,不招人套细胞淋巴瘤 (MCL) | 弥漫性大 B 细胞淋巴瘤 (DLBCL) | 滤泡性淋巴瘤 (FL) | 淋巴瘤非霍奇金 B 细胞 | 转化的滤泡性淋巴瘤 (TFL) | 原发性纵隔 B 细胞淋巴瘤 (PMBCL)新西兰
-
University of Auckland, New ZealandSingapore Institute for Clinical Sciences; Massey University; AgResearch; The Riddet Institute完全的
-
University of Auckland, New Zealand撤销
-
Auckland City HospitalHealth Research Council, New Zealand; Australian and New Zealand College of Anaesthetists完全的
-
Boehringer IngelheimEli Lilly and Company完全的2型糖尿病美国, 澳大利亚, 巴西, 加拿大, 萨尔瓦多, 法国, 大韩民国, 新西兰, 挪威, 西班牙, 台湾
-
Spero TherapeuticsUnited States Department of Defense完全的
-
Innate ImmunotherapeuticsNational Multiple Sclerosis Society; Primorus Clinical Trials完全的